SCHEMBL30926765

SCHEMBL30926765

O=C(Nc1ccc(S(=O)(=O)Nc2cccc(Cl)c2)cc1)c1ccccn1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 6/20 0.77
HDAC6 Q9UBN7 1/20 0.70
POLB P06746 1/20 0.67
GAA P10253 3/20 0.66
GPR27 Q9NS67 3/20 0.66
LMNA P02545 2/20 0.66
TSHR P16473 1/20 0.66
MAPT P10636 2/20 0.65
TP53 P04637 1/20 0.65
KDR P35968 2/20 0.64
NPC1 O15118 1/20 0.64
RAB9A P51151 1/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
ALDH1A1 P00352 1/20 0.61
PKM P14618 1/20 0.61
HTT P42858 1/20 0.61
MEN1 O00255 1/20 0.60
KMT2A Q03164 1/20 0.60
NAMPT P43490 1/20 0.59
AVPR2 P30518 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27180433 1.00 GRM4 (0.77) GRM4HDAC6POLBGAAGPR27
SCHEMBL27181366 0.91 GRM4 (0.74) GRM4HDAC6POLBGAAGPR27
SCHEMBL30926458 0.91 GRM4 (0.74) GRM4HDAC6POLBGAAGPR27
SCHEMBL12197846 0.88 GRM4 (0.85) GRM4POLBGAAGPR27LMNA
SCHEMBL12197830 0.87 GRM4 (1.00) GRM4GAAGPR27LMNATSHR
SCHEMBL12197847 0.87 GRM4 (0.76) GRM4GAAGPR27LMNATSHR
SCHEMBL12197843 0.84 MAPT (0.74) GRM4GAAGPR27LMNATSHR
SCHEMBL12197879 0.84 GRM4 (0.79) GRM4POLBGPR27NPC1RAB9A
SCHEMBL2530324 0.83 GRM4 (1.00) GRM4HDAC6KDRNPC1RAB9A
SCHEMBL29496401 0.83 GRM4 (1.00) GRM4HDAC6KDRNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP GRM4 4166/4885HDAC6 2738/4885POLB 4136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.